GT Biopharma (GTBP) ended 2024 with roughly $4M in cash, enough to fund operations into the second quarter of 2025, Roth MKM tells investors in ...

When a test determined that Walter had hemophilia, his Omaha owner joined a group seeking to raise $50,000 for a clinical ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

Although this initial study was not intended to measure sensor accuracy, Glucotrack noted that the system performed as ...

Nanox.ARC is an FDA, CE Marked, digital multi-source 3D tomosynthesis imaging system, providing advanced radiographic visualization. Nanox.ARC unlocks significant value for medical practices, ...

The Omaha resident, who has adopted and fostered a number of dogs, had traveled to the shelter hoping to adopt a Japanese ...

United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...

Discover insights from Summit Therapeutics' Q4 2024 earnings call, highlighting the Pfizer collaboration, ivonescimab trial expansions, and strong ...

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...

With A$AP Rocky’s Ray-Ban moments, courtroom style has become a cultural phenomenon, blending law, fashion, and branding into ...

Three of Australia's most successful global life sciences plays have reported increased interim profits – with the promise of ...